Aditxt, Inc., a biotech company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1. The company has proposed for the registration to become effective at 5:00 p.m. Eastern Time on June 13, 2024. This request was made under Rule 461 of the Securities Act of 1933. Aditxt's CEO, Amro Albanna, signed the request, which was submitted through the company's legal counsel, Sheppard Mullin Richter & Hampton LLP. The SEC has been asked to notify the company's counsel promptly upon the declaration of the Registration Statement's effectiveness.

Aditxt, Inc., a biotech company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1. The company has proposed for the registration to become effective at 5:00 p.m. Eastern Time on June 13, 2024. This request was made under Rule 461 of the Securities Act of 1933. Aditxt's CEO, Amro Albanna, signed the request, which was submitted through the company's legal counsel, Sheppard Mullin Richter & Hampton LLP. The SEC has been asked to notify the company's counsel promptly upon the declaration of the Registration Statement's effectiveness.